However, as for the SARS-CoV-2 cross-reactive T cells, the contribution of flavivirus cross-reactive CD4+ and CD8 + T cells in protecting humans from infection with heterologous flaviviruses remains to be resolved. The gene discussed is CD8A; the disease is infection.